Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
EBC MAIN: A European Bifurcation Club Trial David Hildick-Smith Sussex Cardiac Centre, UK TVT 2012 EBC MAIN • The European Bifurcation Club Left Main Coronary Study - a randomised comparison of Single versus Dual Stenting for True Bifurcation Left Main Coronary Lesions Hypothesis • “Left main coronary bifurcation lesions (type 1,1,1 or 0,1,1: both LAD and Cx >2.75mm diameter) are best treated with a planned provisional single stent strategy rather than a planned dual stent strategy, with respect to death, target lesion revascularisation and myocardial infarction at 1 year.” Inclusion criteria • Bifurcation distal left main stem stenosis >70% + • • • • • • • • • Ischaemic symptoms +ve non-invasive ischaemia testing +ve FFR LMS IVUS <6mm2 Left main diameter <6mm diameter True bifurcation lesion type 1,1,1 or 0,1,1 LAD and Cx diameter both >=2.75mm Unprotected left main Patient ≥18 years old Exclusion criteria • • • • • • • • • • • • STEMI <72 hours preceding Cardiogenic shock Chronic total occlusion of either vessel >2 other coronary lesions planned for treatment SYNTAX score for planned lesions to be treated >32 LMS trifurcation if all vessels are ≥2.75mm diameter Either bifurcation vessel not suitable for stenting Platelet count ≤50 x 109/mm3 Left ventricular ejection fraction ≤20% Patient life expectancy less than 12 months Participation in another investigational drug or device study Patient unable to give informed consent Study design • • • • • Multicentre Prospective Randomised 450 patients 20 centres Stent Patient with left main stem true bifurcation lesion (Medina class 1,1,1; 0,1,1:LAD and Cx both ≥2.75mm) I I I Suitable for stent treatment I I Consent I I Randomisation to either: I I I I I I I I I I I I I A: planned single stent strategy B: planned dual stent strategy Primary endpoint: Composite at 12 months of death, MI, TVR Endpoints • Primary: • Death, Myocardial infarction and Target Lesion Revascularisation at 12 months • Secondary: • • • • Death, MI, TLR, individually Angina status Stent thrombosis Death, MI, TLR at 3 yrs, 5 yrs Techniques • SINGLE STENT • provisional T according to EBC Consensus 2009 Techniques • DUAL STENT • Operator choice • Ancillary aspects – as per EBC Consensus 2009